The lack of correlation between both IGF-I and IGF-1R and patients' age, tumour size, grade, vascular invasion or the presence of DCIS are in consistence with the findings of Sancak et al [27] who found no association between the serum level of IGF-I and these clinicopathological parameters. This evidence concerns the gene IGF1 and ductal breast carcinoma in situ.